Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
- Citation:
- Leuk Lymphoma vol 57 (10) 2298-306
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Wendy Stock is corresponding author. For submission to Haematologica.
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA032291, U10 CA180861, U10 CA077658, U10 CA180835, U10 CA031946, U10 CA033601, U10 CA180821, U10 CA059518, U10 CA180850, U10 CA101140, U10 CA041287, U10 CA180882, P30 CA016058, P50 GM115279
- Corr. Author:
- Authors:
- Rebecca DeBoer Gregory Koval Flora Mulkey Meir Wetzler Steven Devine Guido Marcucci Richard M. Stone Richard A. Larson Clara D. Bloomfield Susan Geyer Charles G. Mullighan Wendy Stock
- Networks:
- CA043, LAPS-IL057, LAPS-MA036, LAPS-OH007
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-9665, CALGB-10001
- Phases:
- 2, N/A
- Keywords:
- Lymphoid leukemia, Prognostication, Drug resistance, Transcription factor changes